Blend BPC-157 2MG with Thymosin Beta 4 (TB500) 2MG

Blend BPC-157 2MG with Thymosin Beta 4 (TB500) 2MG is a synergistic combination of two synthetic peptides formulated specifically for in vitro laboratory research. These peptides are strictly intended for research purposes only and are not approved for human or animal consumption. All usage should be conducted in controlled laboratory settings under strict experimental protocols.

Both BPC-157 and Thymosin Beta 4 have been explored in preclinical studies for their potential in wound healing, tissue repair, and regenerative research. Animal studies on BPC-157 and Thymosin Beta 4 have investigated their roles in:

• Wound healing^1,2
• Muscle and tendon injuries^3,4
• Vascular growth^1,5
• Gastrointestinal health^6,7

It’s essential to recognize that these studies are preliminary and do not confirm clinical efficacy.

BPC-157 has demonstrated various mechanisms of action in laboratory settings, including:

• Enhancing nitric oxide production
• Activating repair and regeneration cells
• Stimulating growth factor synthesis
• Reducing inflammation⁸

These properties make BPC-157 an intriguing peptide for in vitro studies on tissue healing and cellular regeneration.

Thymosin Beta 4 binds to actin, a protein essential for cellular movement, and supports the migration and differentiation of stem and progenitor cells. Its role in promoting new blood vessel formation and tissue regeneration makes it a valuable asset in cell biology research.⁹

While both BPC-157 and Thymosin Beta 4 exhibit individual benefits, their combined effects have been minimally studied. One exploratory study reported that 75% of subjects receiving both peptides showed improvement in knee pain.¹⁰ However, this study's small sample size and lack of a control group mean these findings are inconclusive and should be regarded as preliminary.

This peptide blend is provided strictly for in vitro laboratory research and is not suitable for clinical, veterinary, or personal use. Application or ingestion outside of controlled research settings may pose significant risks and is prohibited.

The blend is supplied as a white lyophilized powder, with each vial containing a total of 10 mg (2 mg of each peptide).

References

1. Huang T et al. Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther. 2015;9:2485-99.
2. Philp D, Kleinman HK. Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide. Ann N Y Acad Sci. 2010;1194:81-6.
3. Seiwerth S et al. BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle, and bone healing. Curr Pharm Des. 2018;24(18):1972-1989.
4. Xu B et al. Thymosin β4 enhances the healing of medial collateral ligament injury in rat. Regul Pept. 2013;184:1-5.
5. Smart N et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature. 2007;445(7124):177-82.
6. Vukojević J et al. Rat inferior caval vein ligature and new insights with the stable gastric pentadecapeptide BPC 157. Vascul Pharmacol. 2018;106:54-66.
7. Nemolato S et al. Thymosin beta 4 immunoreactivity in fetal and adult gastrointestinal tracts. PLoS One. 2010;5(2):e9111.
8. Chang CH et al. BPC 157 enhances growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066-77.
9. Goldstein AL et al. Thymosin β4: a multifunctional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51.
10. Lee E, Padgett B. Intra-articular injection of BPC 157 for knee pain. Altern Ther Health Med. 2021;27(4):8-13.